Standout Papers

Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-... 2014 2026 2018 2022 395
  1. Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2 (2014)
    Martine Piccart, Gabriel N. Hortobágyi et al. Annals of Oncology

Immediate Impact

10 from Science/Nature 66 standout
Sub-graph 1 of 22

Citing Papers

Fluorescent Probes for Disease Diagnosis
2024 Standout
Deciphering breast cancer: from biology to the clinic
2023 Standout
1 intermediate paper

Works of Fabienne Lebrun being referenced

Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2
2014 Standout

Author Peers

Author Last Decade Papers Cites
Fabienne Lebrun 639 510 487 41 1.2k
Adam Crystal 617 363 578 27 1.6k
José A. Galván 663 263 654 47 1.6k
Sameera R. Wijayawardana 423 383 486 46 1.1k
Linda J. Metheny‐Barlow 370 397 749 36 1.5k
Stephen Leong 584 308 718 25 1.3k
Frank C. Cackowski 551 309 542 41 1.1k
Yu-Chen Lee 484 326 763 35 1.6k
Norma Hernández‐Pedro 328 178 571 50 1.2k
Marc Barry 415 496 726 41 1.7k
Sun-Jin Kim 753 614 776 35 1.7k

All Works

Loading papers...

Rankless by CCL
2026